 | • レポートコード：D005-00387 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、発現用コンピテントセルの世界市場を広く調査・分析し、今後の市場展望をまとめております。発現用コンピテントセルの種類別市場規模（20 *100μl、50 *100μl、100 *100μl、その他）、用途別市場規模（タンパク質発現、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck KGaA、Yeastern Biotech、Takara Bio、Thermo Fisher Scientific、GeneScript Corporation、Agilent Technologies、QIAGEN N.V.、Beijing TransGen Biotech、Promega Corporation、New England Biolabs、Bioline、OriGene Technologies、Bio-Rad Laboratories、Lucigen、Zymo Research ・地域別グローバル市場分析 2015年-2020年 ・発現用コンピテントセルの北米市場（アメリカ、カナダ、メキシコ） ・発現用コンピテントセルのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・発現用コンピテントセルのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・発現用コンピテントセルの南米市場（ブラジル、アルゼンチン） ・発現用コンピテントセルの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：20 *100μl、50 *100μl、100 *100μl、その他 ・用途別分析：タンパク質発現、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Expressed Competent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Expressed Competent Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Expressed Competent Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Expressed Competent Cells market has been segmented into:
20*100μl
50*100μl
100*100μl
Other
By Application, Expressed Competent Cells has been segmented into:
Protein Expression
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Expressed Competent Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Expressed Competent Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Expressed Competent Cells market.
The report offers in-depth assessment of the growth and other aspects of the Expressed Competent Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Expressed Competent Cells Market Share Analysis
Expressed Competent Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Expressed Competent Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Expressed Competent Cells sales, revenue and market share for each player covered in this report.
The major players covered in Expressed Competent Cells are:
Merck KGaA
Yeastern Biotech
Takara Bio
Thermo Fisher Scientific
GeneScript Corporation
Agilent Technologies
QIAGEN N.V.
Beijing TransGen Biotech
Promega Corporation
New England Biolabs
Bioline
OriGene Technologies
Bio-Rad Laboratories
Lucigen
Zymo Research
Table of Contents
1 Expressed Competent Cells Market Overview
1.1 Product Overview and Scope of Expressed Competent Cells
1.2 Classification of Expressed Competent Cells by Type
1.2.1 Global Expressed Competent Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Expressed Competent Cells Revenue Market Share by Type in 2019
1.2.3 20*100μl
1.2.4 50*100μl
1.2.5 100*100μl
1.2.6 Other
1.3 Global Expressed Competent Cells Market by Application
1.3.1 Overview: Global Expressed Competent Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Protein Expression
1.3.3 Other
1.4 Global Expressed Competent Cells Market by Regions
1.4.1 Global Expressed Competent Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Expressed Competent Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Expressed Competent Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Expressed Competent Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Expressed Competent Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Expressed Competent Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Expressed Competent Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck KGaA SWOT Analysis
2.1.4 Merck KGaA Product and Services
2.1.5 Merck KGaA Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Yeastern Biotech
2.2.1 Yeastern Biotech Details
2.2.2 Yeastern Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Yeastern Biotech SWOT Analysis
2.2.4 Yeastern Biotech Product and Services
2.2.5 Yeastern Biotech Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takara Bio
2.3.1 Takara Bio Details
2.3.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takara Bio SWOT Analysis
2.3.4 Takara Bio Product and Services
2.3.5 Takara Bio Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 GeneScript Corporation
2.5.1 GeneScript Corporation Details
2.5.2 GeneScript Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GeneScript Corporation SWOT Analysis
2.5.4 GeneScript Corporation Product and Services
2.5.5 GeneScript Corporation Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 QIAGEN N.V.
2.7.1 QIAGEN N.V. Details
2.7.2 QIAGEN N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 QIAGEN N.V. SWOT Analysis
2.7.4 QIAGEN N.V. Product and Services
2.7.5 QIAGEN N.V. Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beijing TransGen Biotech
2.8.1 Beijing TransGen Biotech Details
2.8.2 Beijing TransGen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beijing TransGen Biotech SWOT Analysis
2.8.4 Beijing TransGen Biotech Product and Services
2.8.5 Beijing TransGen Biotech Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Promega Corporation
2.9.1 Promega Corporation Details
2.9.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Promega Corporation SWOT Analysis
2.9.4 Promega Corporation Product and Services
2.9.5 Promega Corporation Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 New England Biolabs
2.10.1 New England Biolabs Details
2.10.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 New England Biolabs SWOT Analysis
2.10.4 New England Biolabs Product and Services
2.10.5 New England Biolabs Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bioline
2.11.1 Bioline Details
2.11.2 Bioline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bioline SWOT Analysis
2.11.4 Bioline Product and Services
2.11.5 Bioline Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 OriGene Technologies
2.12.1 OriGene Technologies Details
2.12.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 OriGene Technologies SWOT Analysis
2.12.4 OriGene Technologies Product and Services
2.12.5 OriGene Technologies Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bio-Rad Laboratories
2.13.1 Bio-Rad Laboratories Details
2.13.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Bio-Rad Laboratories SWOT Analysis
2.13.4 Bio-Rad Laboratories Product and Services
2.13.5 Bio-Rad Laboratories Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.14 Lucigen
2.14.1 Lucigen Details
2.14.2 Lucigen Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Lucigen SWOT Analysis
2.14.4 Lucigen Product and Services
2.14.5 Lucigen Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.15 Zymo Research
2.15.1 Zymo Research Details
2.15.2 Zymo Research Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Zymo Research SWOT Analysis
2.15.4 Zymo Research Product and Services
2.15.5 Zymo Research Expressed Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Expressed Competent Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Expressed Competent Cells Players Market Share
3.2.2 Top 10 Expressed Competent Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Expressed Competent Cells Revenue and Market Share by Regions
4.2 North America Expressed Competent Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Expressed Competent Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Expressed Competent Cells Revenue and Growth Rate (2015-2020)
4.5 South America Expressed Competent Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Expressed Competent Cells Revenue and Growth Rate (2015-2020)
5 North America Expressed Competent Cells Revenue by Countries
5.1 North America Expressed Competent Cells Revenue by Countries (2015-2020)
5.2 USA Expressed Competent Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Expressed Competent Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Expressed Competent Cells Revenue and Growth Rate (2015-2020)
6 Europe Expressed Competent Cells Revenue by Countries
6.1 Europe Expressed Competent Cells Revenue by Countries (2015-2020)
6.2 Germany Expressed Competent Cells Revenue and Growth Rate (2015-2020)
6.3 UK Expressed Competent Cells Revenue and Growth Rate (2015-2020)
6.4 France Expressed Competent Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Expressed Competent Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Expressed Competent Cells Revenue by Countries
7.1 Asia-Pacific Expressed Competent Cells Revenue by Countries (2015-2020)
7.2 China Expressed Competent Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Expressed Competent Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Expressed Competent Cells Revenue and Growth Rate (2015-2020)
7.5 India Expressed Competent Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
8 South America Expressed Competent Cells Revenue by Countries
8.1 South America Expressed Competent Cells Revenue by Countries (2015-2020)
8.2 Brazil Expressed Competent Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Expressed Competent Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Expressed Competent Cells by Countries
9.1 Middle East & Africa Expressed Competent Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Expressed Competent Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Expressed Competent Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Expressed Competent Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Expressed Competent Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Expressed Competent Cells Market Forecast by Type (2019-2024)
10.3 20*100μl Revenue Growth Rate (2015-2025)
10.4 50*100μl Revenue Growth Rate (2015-2025)
10.5 100*100μl Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Expressed Competent Cells Market Segment by Application
11.1 Global Expressed Competent Cells Revenue Market Share by Application (2015-2020)
11.2 Expressed Competent Cells Market Forecast by Application (2019-2024)
11.3 Protein Expression Revenue Growth (2015-2020)
11.4 Other Revenue Growth (2015-2020)
12 Global Expressed Competent Cells Market Size Forecast (2021-2025)
12.1 Global Expressed Competent Cells Market Size Forecast (2021-2025)
12.2 Global Expressed Competent Cells Market Forecast by Regions (2021-2025)
12.3 North America Expressed Competent Cells Revenue Market Forecast (2021-2025)
12.4 Europe Expressed Competent Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Expressed Competent Cells Revenue Market Forecast (2021-2025)
12.6 South America Expressed Competent Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Expressed Competent Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Expressed Competent Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Expressed Competent Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Expressed Competent Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Expressed Competent Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck KGaA Corporate Information, Location and Competitors
Table 6. Merck KGaA Expressed Competent Cells Major Business
Table 7. Merck KGaA Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 8. Merck KGaA SWOT Analysis
Table 9. Merck KGaA Expressed Competent Cells Product and Solutions
Table 10. Merck KGaA Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Yeastern Biotech Corporate Information, Location and Competitors
Table 12. Yeastern Biotech Expressed Competent Cells Major Business
Table 13. Yeastern Biotech Expressed Competent Cells Total Revenue (USD Million) (2018-2019)
Table 14. Yeastern Biotech SWOT Analysis
Table 15. Yeastern Biotech Expressed Competent Cells Product and Solutions
Table 16. Yeastern Biotech Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takara Bio Corporate Information, Location and Competitors
Table 18. Takara Bio Expressed Competent Cells Major Business
Table 19. Takara Bio Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 20. Takara Bio SWOT Analysis
Table 21. Takara Bio Expressed Competent Cells Product and Solutions
Table 22. Takara Bio Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Expressed Competent Cells Major Business
Table 25. Thermo Fisher Scientific Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Expressed Competent Cells Product and Solutions
Table 28. Thermo Fisher Scientific Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GeneScript Corporation Corporate Information, Location and Competitors
Table 30. GeneScript Corporation Expressed Competent Cells Major Business
Table 31. GeneScript Corporation Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 32. GeneScript Corporation SWOT Analysis
Table 33. GeneScript Corporation Expressed Competent Cells Product and Solutions
Table 34. GeneScript Corporation Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Technologies Corporate Information, Location and Competitors
Table 36. Agilent Technologies Expressed Competent Cells Major Business
Table 37. Agilent Technologies Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 38. Agilent Technologies SWOT Analysis
Table 39. Agilent Technologies Expressed Competent Cells Product and Solutions
Table 40. Agilent Technologies Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. QIAGEN N.V. Corporate Information, Location and Competitors
Table 42. QIAGEN N.V. Expressed Competent Cells Major Business
Table 43. QIAGEN N.V. Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 44. QIAGEN N.V. SWOT Analysis
Table 45. QIAGEN N.V. Expressed Competent Cells Product and Solutions
Table 46. QIAGEN N.V. Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beijing TransGen Biotech Corporate Information, Location and Competitors
Table 48. Beijing TransGen Biotech Expressed Competent Cells Major Business
Table 49. Beijing TransGen Biotech Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 50. Beijing TransGen Biotech SWOT Analysis
Table 51. Beijing TransGen Biotech Expressed Competent Cells Product and Solutions
Table 52. Beijing TransGen Biotech Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Promega Corporation Corporate Information, Location and Competitors
Table 54. Promega Corporation Expressed Competent Cells Major Business
Table 55. Promega Corporation Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 56. Promega Corporation SWOT Analysis
Table 57. Promega Corporation Expressed Competent Cells Product and Solutions
Table 58. Promega Corporation Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. New England Biolabs Corporate Information, Location and Competitors
Table 60. New England Biolabs Expressed Competent Cells Major Business
Table 61. New England Biolabs Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 62. New England Biolabs SWOT Analysis
Table 63. New England Biolabs Expressed Competent Cells Product and Solutions
Table 64. New England Biolabs Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bioline Corporate Information, Location and Competitors
Table 66. Bioline Expressed Competent Cells Major Business
Table 67. Bioline Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 68. Bioline SWOT Analysis
Table 69. Bioline Expressed Competent Cells Product and Solutions
Table 70. Bioline Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. OriGene Technologies Corporate Information, Location and Competitors
Table 72. OriGene Technologies Expressed Competent Cells Major Business
Table 73. OriGene Technologies Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 74. OriGene Technologies SWOT Analysis
Table 75. OriGene Technologies Expressed Competent Cells Product and Solutions
Table 76. OriGene Technologies Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 78. Bio-Rad Laboratories Expressed Competent Cells Major Business
Table 79. Bio-Rad Laboratories Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 80. Bio-Rad Laboratories SWOT Analysis
Table 81. Bio-Rad Laboratories Expressed Competent Cells Product and Solutions
Table 82. Bio-Rad Laboratories Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Lucigen Corporate Information, Location and Competitors
Table 84. Lucigen Expressed Competent Cells Major Business
Table 85. Lucigen Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 86. Lucigen SWOT Analysis
Table 87. Lucigen Expressed Competent Cells Product and Solutions
Table 88. Lucigen Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Zymo Research Corporate Information, Location and Competitors
Table 90. Zymo Research Expressed Competent Cells Major Business
Table 91. Zymo Research Expressed Competent Cells Total Revenue (USD Million) (2017-2018)
Table 92. Zymo Research SWOT Analysis
Table 93. Zymo Research Expressed Competent Cells Product and Solutions
Table 94. Zymo Research Expressed Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Expressed Competent Cells Revenue (Million USD) by Players (2015-2020)
Table 96. Global Expressed Competent Cells Revenue Share by Players (2015-2020)
Table 97. Global Expressed Competent Cells Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Expressed Competent Cells Revenue Market Share by Regions (2015-2020)
Table 99. North America Expressed Competent Cells Revenue by Countries (2015-2020)
Table 100. North America Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Table 101. Europe Expressed Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Expressed Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Expressed Competent Cells Revenue by Countries (2015-2020)
Table 104. South America Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Expressed Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Table 107. Global Expressed Competent Cells Revenue (Million USD) by Type (2015-2020)
Table 108. Global Expressed Competent Cells Revenue Share by Type (2015-2020)
Table 109. Global Expressed Competent Cells Revenue Forecast by Type (2021-2025)
Table 110. Global Expressed Competent Cells Revenue by Application (2015-2020)
Table 111. Global Expressed Competent Cells Revenue Share by Application (2015-2020)
Table 112. Global Expressed Competent Cells Revenue Forecast by Application (2021-2025)
Table 113. Global Expressed Competent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Expressed Competent Cells Picture
Figure 2. Global Expressed Competent Cells Revenue Market Share by Type in 2019
Figure 3. 20*100μl Picture
Figure 4. 50*100μl Picture
Figure 5. 100*100μl Picture
Figure 6. Other Picture
Figure 7. Expressed Competent Cells Revenue Market Share by Application in 2019
Figure 8. Protein Expression Picture
Figure 9. Other Picture
Figure 10. Global Expressed Competent Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Expressed Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Expressed Competent Cells Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Expressed Competent Cells Revenue Market Share in 2019
Figure 19. Global Top 10 Players Expressed Competent Cells Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Expressed Competent Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Expressed Competent Cells Revenue Market Share by Regions (2015-2020)
Figure 23. Global Expressed Competent Cells Revenue Market Share by Regions in 2018
Figure 24. North America Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 25. Europe Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 27. South America Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 29. North America Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 30. North America Expressed Competent Cells Revenue Market Share by Countries in 2019
Figure 31. USA Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 32. Canada Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 34. Europe Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Expressed Competent Cells Revenue Market Share by Countries in 2019
Figure 36. Germany Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 37. UK Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 38. France Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 39. Russia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 40. Italy Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Expressed Competent Cells Revenue Market Share by Countries in 2019
Figure 43. China Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 44. Japan Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 45. Korea Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 46. India Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 48. South America Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 49. South America Expressed Competent Cells Revenue Market Share by Countries in 2019
Figure 50. Brazil Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Expressed Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Expressed Competent Cells Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 55. UAE Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Expressed Competent Cells Revenue and Growth Rate (2015-2020)
Figure 58. Global Expressed Competent Cells Revenue Share by Type (2015-2020)
Figure 59. Global Expressed Competent Cells Revenue Share by Type in 2019
Figure 60. Global Expressed Competent Cells Market Share Forecast by Type (2021-2025)
Figure 61. Global 20*100μl Revenue Growth Rate (2015-2020)
Figure 62. Global 50*100μl Revenue Growth Rate (2015-2020)
Figure 63. Global 100*100μl Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Expressed Competent Cells Revenue Share by Application (2015-2020)
Figure 66. Global Expressed Competent Cells Revenue Share by Application in 2019
Figure 67. Global Expressed Competent Cells Market Share Forecast by Application (2021-2025)
Figure 68. Global Protein Expression Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Expressed Competent Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Expressed Competent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Expressed Competent Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Expressed Competent Cells Revenue Market Forecast (2021-2025)
Figure 74. Europe Expressed Competent Cells Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Expressed Competent Cells Revenue Market Forecast (2021-2025)
Figure 76. South America Expressed Competent Cells Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Expressed Competent Cells Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
アグロバクテリウムトゥメファシエンスコンピテントセルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Agrobacterium tumefaciens Competent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Agr…- 化学的形質転換受容性細胞の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chemically Competent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chemically Compete…
- コンピテントセルクローンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Clone Competent Cell market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Clone Competent Cell mar…
- エレクトロコンピテントセルの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Electrocompetent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Electrocompetent Cells…
- 船舶用燃料電池の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Fuel Cells for Marine Vessels market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fuel Cells for …